Gilead Sciences Chief Financial Officer Dickinson Andrew D sold 3,000 shares at $145.29 per share on September 15, 2026, under SEC transaction code S. The sale represented about 1.8% of his prior share holding, while his reported post-transaction position stood at 164,096 shares.

Key Highlights

  • The transaction occurred on September 15, 2026, under SEC transaction code S.
  • Dickinson Andrew D reported ownership of 164,096 Gilead Sciences shares after the transaction.
  • The sale represented about 1.8% of his prior share holding.

Gilead Sciences (NASDAQ: GILD) Chief Financial Officer Dickinson Andrew D sold 3,000 shares at $145.29 per share. The transaction was completed on September 15, 2026, and involved a reported insider sale of Gilead Sciences stock. The transaction record identifies Dickinson Andrew D as Gilead Sciences' Chief Financial Officer. The reported price was $145.29 per share, with the sale involving 3,000 shares. The record identifies the seller by name and describes the transaction as involving Gilead Sciences shares.

Sale Represented 1.8% of Prior Holding

The sale represented about 1.8% of Dickinson's prior share holding. His reported ownership after the transaction was 164,096 shares. The stated percentage measures the transaction against the insider's own prior position in Gilead Sciences. The post-transaction ownership figure applies after the sale.